Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials

F Shan, R Miao, K Xue, Z Li, Z Li, Z Bu, A Wu, L Zhang… - Cancer Letters, 2016 - Elsevier
Purpose Angiogenesis is a promising therapeutic target to inhibit tumor growth. This review
summarizes data from clinical trials of anti-angiogenic agents in gastric cancer. Design A …

Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials

F Shan, R Miao, K Xue, Z Li, Z Li, Z Bu, A Wu, L Zhang… - Cancer Letters, 2016 - infona.pl
Angiogenesis is a promising therapeutic target to inhibit tumor growth. This review
summarizes data from clinical trials of anti-angiogenic agents in gastric cancer. A systematic …

Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials

F Shan, R Miao, K Xue, Z Li, Z Li, Z Bu… - Cancer …, 2016 - pubmed.ncbi.nlm.nih.gov
Purpose Angiogenesis is a promising therapeutic target to inhibit tumor growth. This review
summarizes data from clinical trials of anti-angiogenic agents in gastric cancer. Design A …

Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials.

F Shan, R Miao, K Xue, Z Li, Z Bu, A Wu, L Zhang… - Cancer Letters, 2015 - europepmc.org
Purpose Angiogenesis is a promising therapeutic target to inhibit tumor growth. This review
summarizes data from clinical trials of anti-angiogenic agents in gastric cancer. Design A …

Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials

F Shan, R Miao, K Xue, Z Li, Z Li, Z Bu, A Wu, L Zhang… - Cancer Letters, 2016 - infona.pl
Angiogenesis is a promising therapeutic target to inhibit tumor growth. This review
summarizes data from clinical trials of anti-angiogenic agents in gastric cancer. A systematic …

[引用][C] Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials

F Shan, R Miao, K Xue, Z Li, Z Li, Z Bu, A Wu… - Cancer …, 2016 - Elsevier Limited